469 studies found for:    Open Studies | "Carcinoma, Hepatocellular"
Show Display Options
Rank Status Study
21 Recruiting A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Hepatoma;   Liver Cell Carcinoma
Interventions: Device: DEB-TACE;   Drug: Sorafenib
22 Unknown  the Efficacy and Safety of Ginsenoside Rg3 Capsule in Prevention of Postoperative Recurrence of Hepatocellular Carcinoma
Conditions: Stage I Hepatocellular Carcinoma;   Stage II Hepatocellular Carcinoma
Interventions: Drug: the ginsenoside Rg3;   Drug: Placebo
23 Unknown  Environmental, Metabolic and Nutritional Factors of Hepatocellular Carcinoma in Cirrhotic Patients
Conditions: Cirrhosis With Hepatocellular Carcinoma;   Cirrhosis Without Hepatocellular Carcinoma
Interventions: Biological: Serum, plasma and DNA samples;   Procedure: Radiological exploration by CT scan or MRI
24 Recruiting A Study of LY2157299 in Participants With Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: LY2157299;   Drug: Sorafenib
25 Not yet recruiting MiRNA as a Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular;   Marker, Biological
Intervention:
26 Unknown  Circulating Tumor Cells for Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular;   Neoplasm Circulating Cells
Intervention:
27 Recruiting Role of Huachansu in Treating Hepatocellular Carcinoma and the Correlation With Na+/K+-ATPase
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Huachansu;   Other: TACE
28 Unknown  A Dose-escalation Study of Lipotecan® Plus Radiotherapy in Locally Advanced Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Drug: Lipotecan® (TLC388)
29 Recruiting Study of Regorafenib After Sorafenib in Patients With Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Regorafenib (BAY73-4506);   Drug: Placebo
30 Recruiting Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: 5-FU;   Drug: Mitomycin;   Drug: sorafenib
31 Not yet recruiting Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation
Conditions: Carcinoma, Hepatocellular;   Neoplastic Cells, Circulating
Interventions: Procedure: TACE;   Drug: Epirubicin;   Drug: lipiodol
32 Recruiting Phase I/II Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Biological: OBP-301
33 Recruiting TACE Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Procedure: Thermal Ablation;   Drug: EADM;   Drug: Ultra-fluid lipiodol;   Other: Gelatin sponge articles
34 Unknown  The Role of Low Molecular Weight Heparins (LMWH) Combined With Transarterial Chemoembolization (TACE) in Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: LMWH;   Procedure: TACE
35 Recruiting Study of Apatinib After Systemic Therapy(Chemotherapy and/or Targeted Therapy) in Patients With Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Apatinib;   Drug: Placebo
36 Recruiting A Study of Hypoxia-inducible Factor 1a (HIF1A) Messenger Ribonucleic Acid (mRNA) Antagonist (RO7070179), to Demonstrate Proof-of-mechanism in Adult Participants With Hepatocellular Carcinoma (HCC)
Condition: Carcinoma, Hepatocellular
Intervention: Drug: RO7070179
37 Not yet recruiting Pembrolizumab (Keytruda) in Advanced Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Pembrolizumab;   Procedure: Peripheral Blood Sample (optional);   Genetic: Tumor Tissue Collection (optional)
38 Not yet recruiting Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCC
Condition: Carcinoma, Hepatocellular
Interventions: Drug: TACE containing As2O3;   Drug: TACE containing placebo
39 Unknown  TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Recombinant Human Adenovirus Type 5 Injection;   Procedure: Transartery Chemoembolization
40 Unknown  Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Liver Cancer
Interventions: Procedure: Radiofrequency ablation;   Procedure: TACE

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years